CXADR and urinary bladder cancer: Previous reports have shown that the extracellular and transmembrane domains of hCAR, together with the first two amino acids of the cytoplasmic domain, are required for its biological activity in suppressing growth in human prostate and bladder cancer cells (Okegawa et al, 2000,2001).